Searched for
CARBOPLATIN
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...
- India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...
- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- Cancer drug makers seek 50% price hike as platinum surge hits production viabilityLocal drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...
- AstraZeneca gets CDSCO nod to market cancer drug Imfinzi for additional indicationAstraZeneca Pharma India has secured approval from India's drug regulator for Durvalumab, marketed as Imfinzi. This new indication allows i...
- Venus Remedies get market authorisations for two cancer drugs from Morocco, PhilippinesVenus Remedies Ltd has received marketing authorisations for two key oncology drugs, carboplatin and bortezomib, from Morocco and the Phili...
- Glenmark, Particle Sciences to develop generic cancer drugThe partnership will develop and market a generic version of Celgene's ABRAXANE which is used in treatments of breast and lung cancers.
- Zydus Cadila gets USFDA nod for cancer treatment drugZydus Cadila has received approval from the US health regulator to market carboplatin injection used for the treatment of cancer in the Ame...
- Antibiotics to insulin: Key drugs to cost 4% moreBesides, the govt regulates prices of all other medicines and companies are allowed to hike prices of such drugs by only up to 10% in a yea...
- Taking the toxin out of your cancer treatmentRA Sengupta and Shiladitya Mashelkar have set up a Delhi-based co, Invictus Oncology, to take a modified Cisplatin to the market.
- Strides receives USFDA approval for two cancer drugsDrug firm Strides Arcolab today said it has received approval from the US health regulator to market two generic cancer drugs in the Americ...
- Dabur Pharma net up; in talks for acquisitionsDabur Pharma’s net profit has increased to Rs 2.7 crore for the quarter ended March 31, 2007 from Rs 20.6 lakh in the corresponding period ...
- Dabur Pharma Q4 net up 13 foldSpurred by better product mix and controlled expenses in manufacturing, Dabur Pharma's net profit in the fourth quarter ended March 31 grew...
- Dabur Pharma sets arm in US to tap oncology mktDabur Pharma on Wednesday said it has set up a subsidiary company in the US, which will be directly responsible for sales, marketing and di...
- Abbott biotech arm to sell Dabur cancer drugs in USIndia’s largest maker of cancer therapies, Dabur Pharma, has tied up with the biotech arm of US drug major Abbott Laboratories to make a fo...
- Better product mix spurs Dabur Pharma Q2The company's net sales in the period went up by 23.5 per cent at Rs 97.79 crore .
Load More
